Novartis picks Sanjay Murdeshwar of AstraZeneca to lead its India business
Murdeshwar according to his current LinkedIn profile is the Global Vice President, Cardio-Renal business at Astrazeneca. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2019 Category: Pharmaceuticals Source Type: news

Cipla appoints Dr Raju Mistry as global chief people officer
Mistry is a veteran Human Resources (HR) professional with over 27 years of global experience across diverse sectors. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for 2 generic products
The product is generic version of Sanofi-Aventis US LLC's Aubagio tablets in the same strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2019 Category: Pharmaceuticals Source Type: news

Torrent Pharma recalls over 10.78 lakh bottles of hypertension drug from US
The US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2019 Category: Pharmaceuticals Source Type: news

Lupin seeks more time from commerce ministry to complete Indore SEZ project
Company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations - metered dose inhalers and dry powder inhalers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2019 Category: Pharmaceuticals Source Type: news

Granules India gets USFDA nod for pain relief drug
The approved product is bioequivalent to the reference listed drug product (RLD), Tylenol tablets, extended release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2019 Category: Pharmaceuticals Source Type: news

Hair in one vail, Aurobindo recalls 88k Lidocaine injections from US
According to a notification put up by the US Drug regulator in its website, these vials were manufactured in India for AuroMedics Pharna LLC. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2019 Category: Pharmaceuticals Source Type: news

Many essential drugs priced much higher than manufacturing cost: WHO
Even off patent drugs which are in the market for long and commonly used for diseases like HIV, tuberculosis and malaria are priced very high. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2019 Category: Pharmaceuticals Source Type: news

Government invites initial bids for strategic sale of IMPCL
IMPCL is engaged in manufacture and supply of 'ayurvedic' and 'unani' medicines and is under the Ministry of AYUSH. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's acquires a portfolio of 42 ANDAs in US
These products will require to be technology transferred and could be launched within the next one to two years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 13, 2019 Category: Pharmaceuticals Source Type: news

Indian execs 'named' in US pharma case
The Indian generic makers named in the lawsuit are Aurobindo, Dr Reddy ’s, Emcure, Glenmark, and Zydus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 11, 2019 Category: Pharmaceuticals Source Type: news

Kool-ex cold chain bets on changing pharma distribution guidelines
The cold chain logistics industry expects these guidelines to kick-in before the end of 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 11, 2019 Category: Pharmaceuticals Source Type: news

Lupin launches generic antidepressant tablets in US
The company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food and Drug Administration. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 10, 2019 Category: Pharmaceuticals Source Type: news

Lupin recalls over 12K cartons of birth control tablets from US market
The product was manufactured by Lupin Ltd at its Pithampur facility in Madhya Pradesh. The voluntary ongoing nationwide recall is a class II recall, the report by the regulator said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 7, 2019 Category: Pharmaceuticals Source Type: news

After Daiichi plea, SC stays religare finvest-initiated insolvency at 23 companies
Religare Finvest filed insolvency petitions in July last year on grounds that these companies had defaulted on loans of Rs 1,900 crore taken from the NBFC. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 6, 2019 Category: Pharmaceuticals Source Type: news

Prepare plan to pay Daiichi Sankyo or go to jail for contempt, Supreme Court tells Singh brothers
The contempt pleas have been listed for hearing on April 11, which means they have until then to devise a plan to pay the amount. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 6, 2019 Category: Pharmaceuticals Source Type: news

SC dissatisfied over replies filed by ex-Ranbaxy promoters, will hear contempt petition on Apr 11
A bench headed by Chief Justice Ranjan Gogoi said it will now straightaway hear the contempt petition against the Singh brothers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 5, 2019 Category: Pharmaceuticals Source Type: news

Emcure to launch generic breast cancer medicine
Eribulin, sold by Japanese drug maker Eisai under brand name Halaven, is used to treat HER 2 negative patients. It costs Rs 5,000 per vial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 3, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's subsidiary sells, assigns US rights for 3 brands to Encore Dermatology
CEO G V Prasad said the announcement is in line with its renewed strategy to enable us achieve self-sustainability (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2019 Category: Pharmaceuticals Source Type: news

Strides arm and its partner get USFDA nod for hypokalemia treatment drug
The approved product, used in treatment of patients with hypokalemia, is a generic version of Merck, Inc's Potassium Chloride extended-release tablets, a regulatory filing said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2019 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drug
The product will be manufactured at the group's manufacturing facility at SEZ in Ahmedabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2019 Category: Pharmaceuticals Source Type: news

Price cuts will bring down quality of cancer care: Dr BS Ajay Kumar
Dr Ajaykumar says that instead of bringing price cuts, the government should bring cashless healthcare system. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 1, 2019 Category: Pharmaceuticals Source Type: news

NPPA approves hike in prices of coronary stents
As per the new prices notified by the National Pharmaceutical Pricing Authority (NPPA), a bare metal stent (BMS) would now cost Rs 8,261, while the drug eluting stent (DES) will cost Rs 30,080. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 1, 2019 Category: Pharmaceuticals Source Type: news

CCI to hold off Monsanto probe for now
The CCI had initiated a probe against the company and the role of its officials and directors following a complaint by several local seed companies led by Nuziveedu Seeds. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 1, 2019 Category: Pharmaceuticals Source Type: news

General Atlantic to acquire Rubicon as Everstone Cap exits
The acquisition would mark General Atlantic ’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 31, 2019 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma, Lupin recall drugs in US market
Besides, Mumbai-based Lupin is also recalling 3,200 bottles of Testosterone Topical solution in the US for issues with the container. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 31, 2019 Category: Pharmaceuticals Source Type: news

Jubilant Life Sciences settles IFC loan with USD 135 mn payout
Jubilant Pharma Limited (JPL), a wholly-owned subsidiary of the company, has redeemed zero coupon convertible loan with IFC based on mutual agreement, Jubilant Life Sciences said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 29, 2019 Category: Pharmaceuticals Source Type: news

NCLT sees violation of Sec 29(A) in Sterling Biotech case
For the second time, the NCLT has questioned the motive of Sterling Biotech's lenders, led by Andhra Bank. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 28, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for erectile dysfunction drug
The company currently has a total of 89 ANDA approvals (77 final approvals and 12 tentative approvals) from USFDA, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches erectile dysfunction treatment drug in US
The approved products is a therapeutic equivalent generic version of Cialis (tadalafil) tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2019 Category: Pharmaceuticals Source Type: news

How can absconding promoters make one-time-settlement offers, NCLT asks Sterling Biotech lenders
The four promoters of Sterling Biotech are absconding and are facing extradition orders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 26, 2019 Category: Pharmaceuticals Source Type: news

Sun Pharma receives 483 for Baska facility, co says responded to USFDA
At the conclusion of the inspection, the US FDA issued a Form 483, with one observation for which the Company has submitted the response to the US FDA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2019 Category: Pharmaceuticals Source Type: news

Government notifies new rules for drugs and clinical trials
The new rules will ensure patient safety, as they would be enlisted for trials with informed consent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2019 Category: Pharmaceuticals Source Type: news

Genes2Me- Bringing New Healthcare Paradigm with Genomics
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2019 Category: Pharmaceuticals Source Type: news

Jubilant Life's Nanjangud facility may face regulatory action by USFDA
Jubilant Life Sciences said USFDA's announcement will not have any impact on the existing revenues from operations of this facility. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2019 Category: Pharmaceuticals Source Type: news

Pharma MNCs wary of illegal import of innovator drugs
The Organisation of Pharmaceutical Producers of India claims the rampant and unchecked import of innovator drugs was adversely affecting the revenue of India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Abbott jumps on to digital health service bandwagon
Abbott will also look at partnering with e-pharmacies, diagnostic chains and physicians to provide patients with discounts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 20, 2019 Category: Pharmaceuticals Source Type: news

Why biotechnology can be Indian economy's next success story
In the span of a decade beginning in 2007, the industry has grown exponentially in size from about $2 billion to over $11 billion in terms of revenue. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2019 Category: Pharmaceuticals Source Type: news

USFDA classifies Lupin's Somerset facility as 'Official Action Indicated'
'Official Action Indicated', means approvals of pending applications or supplements from this site maybe withheld. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2019 Category: Pharmaceuticals Source Type: news

SC asks ex-Ranbaxy promoters to apprise how they'll comply with Rs 3500 cr arbitral award
The top court asked for a concrete plan on how they will comply with the tribunal's order. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 14, 2019 Category: Pharmaceuticals Source Type: news

Baring set to acquire health tech co AGS in Rs 2,230cr deal
The Chennai and Newark-based AGS provides a host of services, including medical billing, claim submission, denial management and medical coding. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 14, 2019 Category: Pharmaceuticals Source Type: news

Unichem Labs gets USFDA nod to market Allopurinol tablets
The product will be commercialised from company's Ghaziabad plant, Unichem Laboratories said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2019 Category: Pharmaceuticals Source Type: news

Drug regulator directs J & J to pay Rs 74 lakhs to a patient
After nearly a year of setting up a committee under Dr Arun Kumar Agarwal, a report was submitted to the health ministry with its final recommendation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2019 Category: Pharmaceuticals Source Type: news

GST relief for pharma samples, discount offers
Close to two years after GST was launched, the finance ministry sought to provide some answers on the question of discounts and freebies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2019 Category: Pharmaceuticals Source Type: news

Suven Life Sciences to set up subsidiary in US, to infuse $75 million
The board of directors has approved investment of USD 75 million in the said WOS for new business opportunities and acquisitions,the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 9, 2019 Category: Pharmaceuticals Source Type: news

Prices of 390 non-scheduled cancer medicines slashed by up to 87 per cent
This move is expected to benefit 22 lakh cancer patients in the country and would result in annual savings of around Rs 800 crore to the patients, the release said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2019 Category: Pharmaceuticals Source Type: news

Whistleblower says Sun Pharma gave doctors gifts through a subsidiary
Allegations are that Sun Pharma used a subsidiary to give gifts to doctors — a blatant violation of rules. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2019 Category: Pharmaceuticals Source Type: news

Suven plans to buy US-based Rising Pharmaceuticals' assets
Shore Suven Pharma Inc is a joint venture between Suven Life Sciences and Shore Pharma Investments LLC of USA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2019 Category: Pharmaceuticals Source Type: news

Mumbai HC asks Nuziveedu Seeds Ltd to pay Rs 138 cr dues of Mahyco Monsanto Biotech
MMBL sells Bt technology to cotton seed companies under sub-licence agreements. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 7, 2019 Category: Pharmaceuticals Source Type: news

India requires pragmatic compulsive licensing system: Cipla
The industry doyen pointed out that 70 percent of the major drugs are in-licensed and it is what India should look to do. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 6, 2019 Category: Pharmaceuticals Source Type: news